In novum - Company finances
|
EUR
|
2018
From: 2018-11-06
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | 79,088 | 126,123 | 288,275 | 486,312 | 770,797 | 915,671 | 901,907 |
| Profit before tax | -2,295 | -9,788 | 22,530 | 51,168 | 45,043 | 149,877 | 152,081 | -21,980 |
| Net profit | -2,295 | -9,788 | 21,842 | 48,483 | 38,553 | 127,449 | 129,349 | -21,980 |
| Equity | 5,206 | -4,582 | 17,259 | 65,742 | 95,295 | 197,444 | 286,498 | 264,518 |
| Liabilities | 30,251 | 29,378 | 45,927 | 47,370 | 76,514 | 117,411 | 116,665 | 238,152 |
| Non-current assets | 0 | 958 | 1,455 | 75,423 | 86,350 | 133,665 | 135,420 | 142,430 |
| Current assets | 35,457 | 23,838 | 61,634 | 37,097 | 84,246 | 204,253 | 291,949 | 358,310 |
| Total assets | 35,457 | 24,796 | 63,089 | 112,520 | 170,596 | 337,918 | 427,369 | 500,740 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 68,382 | 111,931 | 109,538 |
| Social insurance contributions | - | - | - | - | - | 18,658 | 30,189 | 41,887 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | +59.5% | +128.6% | +68.7% | +58.5% | +18.8% | -1.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -6.5% | -39.5% | 34.6% | 43.1% | 22.6% | 37.7% | 30.3% | -4.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -44.1% | - | 126.6% | 73.7% | 40.5% | 64.5% | 45.1% | -8.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -12.4% | 17.3% | 16.8% | 7.9% | 16.5% | 14.1% | -2.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | -12.4% | 17.9% | 17.7% | 9.3% | 19.4% | 16.6% | -2.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 5.8 | - | 2.7 | 0.7 | 0.8 | 0.6 | 0.4 | 0.9 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 32,726 | 42,041 | 91,033 | 112,227 | 144,525 | 129,272 | 121,605 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
In novum - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-11-16 | 2023-11-21 | 308.80 |
| 2023-10-17 | 2023-10-30 | 308.80 |
| 2023-09-18 | 2023-09-28 | 308.80 |
| 2023-08-25 | 2023-08-30 | 308.80 |
| 2023-08-17 | 2023-08-24 | 578.80 |
| 2023-07-26 | 2023-08-01 | 632.80 |
| 2023-07-24 | 2023-07-25 | 632.93 |
| 2023-07-18 | 2023-07-23 | 629.25 |
| 2023-06-20 | 2023-06-29 | 629.25 |
| 2023-06-16 | 2023-06-19 | 737.25 |
| 2023-05-25 | 2023-05-31 | 737.25 |
| 2023-05-16 | 2023-05-24 | 2016.85 |
| 2023-05-02 | 2023-05-15 | 791.25 |
| 2023-04-18 | 2023-04-28 | 791.25 |
| 2023-03-29 | 2023-04-10 | 791.25 |
| 2023-03-16 | 2023-03-28 | 845.25 |
| 2023-02-27 | 2023-03-01 | 845.25 |
| 2023-02-17 | 2023-02-26 | 899.25 |
| 2023-01-17 | 2023-01-31 | 953.25 |
| 2022-12-16 | 2022-12-29 | 1007.25 |
| 2022-11-24 | 2022-11-30 | 1061.25 |
| 2022-11-21 | 2022-11-23 | 1115.25 |
| 2022-11-17 | 2022-11-18 | 1115.25 |
| 2022-10-31 | 2022-11-16 | 66.90 |
| 2022-10-18 | 2022-10-30 | 1169.25 |
| 2022-10-05 | 2022-10-17 | 127.98 |
| 2022-09-16 | 2022-10-04 | 1223.25 |
| 2022-09-07 | 2022-09-15 | 66.03 |
| 2022-08-31 | 2022-09-06 | 108.78 |
| 2022-08-23 | 2022-08-30 | 1277.25 |
| 2022-08-03 | 2022-08-22 | 43.99 |
| 2022-08-01 | 2022-08-02 | 124.18 |
| 2022-07-25 | 2022-07-31 | 1277.25 |
| 2022-07-18 | 2022-07-24 | 1331.25 |
| 2022-07-01 | 2022-07-17 | 349.83 |
| 2022-06-16 | 2022-06-30 | 1331.25 |
| 2022-06-13 | 2022-06-15 | 574.93 |
| 2022-05-31 | 2022-06-12 | 628.93 |
| 2022-05-17 | 2022-05-30 | 1385.25 |
| 2022-04-29 | 2022-05-16 | 485.81 |
| 2022-04-26 | 2022-04-28 | 1439.25 |
| 2022-04-19 | 2022-04-25 | 1493.25 |
| 2022-04-07 | 2022-04-18 | 539.81 |
| 2022-03-16 | 2022-04-06 | 1547.25 |
| 2022-03-14 | 2022-03-15 | 498.26 |
| 2022-02-17 | 2022-03-13 | 1601.28 |
| 2022-02-10 | 2022-02-16 | 647.84 |
| 2022-02-09 | 2022-02-09 | 701.84 |
| 2022-01-18 | 2022-02-08 | 1709.28 |
| 2022-01-03 | 2022-01-17 | 861.59 |
| 2021-12-16 | 2022-01-02 | 1763.28 |
| 2021-12-09 | 2021-12-15 | 736.58 |
| 2021-11-16 | 2021-12-08 | 1817.25 |
| 2021-11-15 | 2021-11-15 | 790.58 |
| 2021-10-18 | 2021-11-14 | 1871.25 |
| 2021-10-01 | 2021-10-17 | 1076.86 |
| 2021-09-16 | 2021-09-30 | 1925.25 |
In novum - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-10-03 | 2025-10-07 | 93.82 |
| 2024-11-28 | 2024-11-29 | 0.07 |
| 2024-11-09 | 2024-11-18 | 9.09 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
In novum, UAB (code 304945917) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In the latest financial year 2025, the company generated revenue of €901.9K, slightly below 2024 revenue of €915.7K, but still well above €770.8K in 2023. Profitability weakened materially in 2025: net profit turned into a loss of €22.0K, compared with net profit of €129.3K in 2024 and €127.4K in 2023. This pushed the profit margin to -2.4% from 14.1% in 2024 and 16.5% in 2023. The balance sheet expanded further, with total assets rising to €500.7K in 2025 from €427.4K a year earlier and €337.9K in 2023. Equity stood at €264.5K, while liabilities increased to €238.2K, indicating higher leverage than in previous years. Long-term assets were €142.4K and short-term assets €358.3K. Key indicators for 2025 show ROE of -8.3%, ROA of -4.4%, debt-to-equity of 0.90, and asset turnover of 1.80x. Revenue per employee was €128.8K, while profit per employee was -€3.1K.